10519583

Source:http://linkedlifedata.com/resource/pubmed/id/10519583

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0012727, umls-concept:C0019080, umls-concept:C0032143, umls-concept:C1273870, umls-concept:C1533685
pubmed:issue	10
pubmed:dateCreated	1999-10-18
pubmed:abstractText	To investigate the efficacy and safety of treating thick submacular hemorrhages with intravitreous tissue plasminogen activator (tPA) and pneumatic displacement.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10519583-11097563, http://linkedlifedata.com/resource/pubmed/commentcorrection/10519583-11097565
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7802443
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Fluorocarbons, http://linkedlifedata.com/resource/pubmed/chemical/Sulfur Hexafluoride, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator, http://linkedlifedata.com/resource/pubmed/chemical/perflutren
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0161-6420
pubmed:author	pubmed-author:BlodiB ABA, pubmed-author:ElnerS GSG, pubmed-author:HassanA SAS, pubmed-author:JohnsonM WMW, pubmed-author:PolinerL SLS, pubmed-author:RegilloC DCD, pubmed-author:SchneidermanT ETE, pubmed-author:TornambeP EPE
pubmed:issnType	Print
pubmed:volume	106
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1900-6; discussion 1906-7
pubmed:dateRevised	2008-5-30
pubmed:meshHeading	pubmed-meshheading:10519583-Adolescent, pubmed-meshheading:10519583-Adult, pubmed-meshheading:10519583-Aged, pubmed-meshheading:10519583-Aged, 80 and over, pubmed-meshheading:10519583-Aneurysm, pubmed-meshheading:10519583-Eye Injuries, pubmed-meshheading:10519583-Female, pubmed-meshheading:10519583-Fibrinolytic Agents, pubmed-meshheading:10519583-Fluorocarbons, pubmed-meshheading:10519583-Humans, pubmed-meshheading:10519583-Injections, pubmed-meshheading:10519583-Macula Lutea, pubmed-meshheading:10519583-Macular Degeneration, pubmed-meshheading:10519583-Male, pubmed-meshheading:10519583-Middle Aged, pubmed-meshheading:10519583-Postoperative Complications, pubmed-meshheading:10519583-Prone Position, pubmed-meshheading:10519583-Retinal Hemorrhage, pubmed-meshheading:10519583-Retinal Vessels, pubmed-meshheading:10519583-Retrospective Studies, pubmed-meshheading:10519583-Sulfur Hexafluoride, pubmed-meshheading:10519583-Thrombolytic Therapy, pubmed-meshheading:10519583-Tissue Plasminogen Activator, pubmed-meshheading:10519583-Treatment Outcome, pubmed-meshheading:10519583-Visual Acuity, pubmed-meshheading:10519583-Vitreous Body
pubmed:year	1999
pubmed:articleTitle	Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
pubmed:affiliation	W. K. Kellogg Eye Center, Department of Ophthalmology, University of Michigan School of Medicine, Ann Arbor 48105, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Multicenter Study